Bilgehan Aygen
Erciyes, 38030, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Effectiveness and Safety of Glecaprevir/Pibrentasvir Combination Therapy in Patients Diagnosed with Chronic Hepatitis C.
Journal: Journal of clinical practice and research
Published: October 15, 2024
The Efficacy of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients and the Impact of the COVID-19 Pandemic: Multicenter Real-Life Data.
Journal: Infectious diseases & clinical microbiology
Published: March 23, 2024
Investigation of Efficacy and Safety in Chronic Hepatitis B Patients Receiving Tenofovir Alafenamide Treatment.
Journal: Journal of clinical practice and research
Published: January 19, 2024
The efficacy of mesenchymal stem cell treatment and colistin-fosfomycin combination on colistin-resistant Acinetobacter baumannii sepsis model.
Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
Published: December 25, 2022
Healthcare-Related HCV Genotype 4d Infections in Kayseri, Turkey.
Journal: The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
Published: September 13, 2022
Real-World Data from Turkey: Is Sofosbuvir/Ledipasvir With or Without Ribavirin Treatment for Chronic Hepatitis C Really Effective?
Journal: The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
Published: May 07, 2021
Real-world efficacy, safety, and clinical outcomes of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: The Turkey experience experience.
Journal: The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
Published: May 16, 2020
A micro-elimination approach to addressing hepatitis C in Turkey.
Journal: BMC health services research
Published: May 06, 2019
Effectiveness of fixed-dose combination of paritaprevir, ritonavir, ombitasvir, and dasabuvir in patients with chronic hepatitis C virus infection and chronic kidney diseases: real-life experiences.
Journal: European journal of gastroenterology & hepatology
Published: January 24, 2019
Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus report.
Journal: The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
Published: May 15, 2018
Last Updated: 09/26/2026